Neuroscience Team Recognized as Unit of Distinction

Community NewsNews
429

Translate to Spanish or other 102 languages!

Colleagues from RGRH’s Critical Care - Progressive Care Unit, Recipient of HCA Healthcare’s the Neuroscience Unit of Distinction. Courtesy Photo RGRH
Colleagues from RGRH’s Critical Care – Progressive Care Unit, Recipient of HCA Healthcare’s the Neuroscience Unit of Distinction. Courtesy Photo RGRH

Mega Doctor News

- Advertisement -

McALLEN, Texas – Rio Grande Regional Hospital (RGRH) is proud and excited to announce that the Neuroscience team was recently recognized as a Recipient of the HCA Healthcare Critical Care – Progressive Care Unit of Distinction.  A total of 202 nursing units from across the country were recognized as top-performing nursing units. 

Units of Distinction are categorized in the top five percent of all HCA Healthcare medical-surgical, critical care, emergency services, surgical services, behavioral health, women’s and children’s nursing units, pediatrics/PICU, and inpatient rehabilitation units.  The top six to 10  percent of all HCA Healthcare units earned honorable mention designations. Our quality of care includes a multidisciplinary approach that consists of emergency room physicians, vascular-trained neurologists available 24-7, neurosurgeons, cardiologists, and an excellent rehabilitation team. 

Congratulations to the Neuroscience team for raising the bar and for their continued commitment to our mission, “Above all else, we are committed to the care and improvement of human life.”  

- Advertisement -

To learn more about the Stroke and Neurosciences programs, visit RioHealth.com.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Falls Can Be a Serious Threat with Heat Disease 
Next article
How the Heart Repairs After a Heart Attack

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.

DHR Health Burn Surgeon Urges Public to Avoid Preventable Risks

Many of the most serious burn and trauma injuries can be prevented by avoiding unnecessary risks, according to Dr. R. Dewayne Edwards, chief burn surgeon, surgical critical care and trauma surgeon at DHR Health, who said public awareness and timely medical care remain essential to improving patient outcomes.
- Advertisement -